All three of the included studies performed immunohistochemistry examination on AdCC primary tumours and metastases biopsies to evaluate PSMA staining and reported variable PSMA expression in cancer cells, ranging from <1% to 95% in local recurrences as well as distant metastases [37,38,39]. This evidence concerns the gene FOLH1 and neoplasm.